Health Canada6 Oct 2026
Carvedilol 25 mg Tablets: Out-of-specification (Impurity)
Health Canada published a recall notice for Carvedilol 25 mg Tablets: Out-of-specification (Impurity) on 6 Oct 2026. It is one of 311 notices of this kind from Health Canada since 2 Apr 2026 in AreaZine's record.
Recall
The recall notice
- Issued by
- Health Canada
- Issued
- 6 Oct 2026
- Recall type
- Health product recall
- Companies
- Pro Doc Ltée2925 boul. Industriel, · Laval, QC H7L 3W9
- Official source
- Health Canada: the notice at its source
The latest from Health CanadaEvery warning and recall in Canada
Source: Health Canada: the notice at its source. AreaZine rebuilds this page from the agency's record; the agency's page is the one to act on. Contains information licensed under the Open Government Licence – Canada.
The notice as issued
Issue: The impurity, N-nitroso-carvedilol, may be out of specification in the affected lots. What you should do What to do: Verify if your product is affected. Consult your healthcare provider prior to discontinuing use of the affected product, or for any health concerns. Contact the recalling firm if you have any questions about the recall. Report any health product related side effects to Health Canada. Report any other health product safety complaints to Health Canada. Additional information Background Affected products: Brand Product Name Market Authorization Dosage Form Strength Lot Number Pro Doc CARVEDILOL DIN 02324539 Tablet 25 MG 650921 651648 654750 656546 658261 659716 661963 663440 665341 667133 Issue
Source: Health Canada: the notice at its source. The text is the agency's, unedited. Contains information licensed under the Open Government Licence – Canada.